FDA Authorizes New OTC Naloxone Nasal Spray for Opioid Overdose Reversal

The U.S. Food and Drug Administration has approved Rextovy, a 4-milligram naloxone nasal spray, for over-the-counter sale. This decision increases public access to medication that can reverse opioid overdoses. The new approval offers an additional readily available option for emergency treatment.